Incidence of Recurrent Major Bleeding and its Impact on Survival in LVAD Patients: A Multistate Analysis
8 affiliations
- 1Department of Thrombosis and Haemostasis Leiden University Medical Center Leiden Netherlands
- 2Department of Cardiology Leiden University Medical Center Leiden Netherlands
- 3Department of Cardiothoracic Surgery Leiden University Medical Center Leiden Netherlands
- 4Department of Clinical Epidemiology Leiden University Medical Center Leiden Netherlands
- 5Department of Clinical Pharmacology and Toxicology Leiden University Medical Center Leiden Netherlands
- 6Department of Biomedical Data Science Leiden University Medical Center Leiden Netherlands
- 7Mathematical Institute, Leiden University Leiden Netherlands
- 8Princess Máxima Center for Paediatric Oncology Utrecht Netherlands
Abstract
Introduction Major bleeding frequently complicates the clinical course of left ventricular assist device (LVAD) therapy. However, data on recurrent major bleeding in destination therapy (DT) patients, as well as its impact on survival, are limited.
Methods Single-center cohort of 122 predominantly DT LVAD between 2010 and 2024. A multistate model was estimated to evaluate first and recurrent major bleeding, and all-cause mortality. Patients who died within 14 days following implantation were excluded from the analysis.
Results For the final analysis 116 patients (90 HeartWare HVAD; 26 HeartMate 3) were included; median age at implantation was 64 years (IQR 59–69 years); 80% were male and 56% had ischemic heart failure. During a follow-up period totaling 300 patient-years, 155 major bleeding episodes occurred in 60 patients. Half of the patients who experienced a first major bleeding ( n = 60) went on to develop a subsequent recurrence ( n = 30). Recurrence often occurred within a short interval after the initial major bleeding. Among these recurrences, 43% occurred at the same site as the initial major bleeding.
Conclusion Following an initial major bleeding, LVAD patients frequently experienced either recurrent major bleeding or death within a short interval. The overall incidence of (recurrent) major bleeding was high. These findings highlight the burden of recurrent bleeding events and their impact on DT LVAD patients.
Related
- Risk factors for recurrent variceal bleeding after TIPS in cirrhotic patients with esophagogastric variceal hemorrhage: a single-center retrospective study
- Improved multistate survival in younger AML patients over time
- Incidence of Osteoradionecrosis and Dental Implant Survival in Patients With Irradiated Head and Neck Malignancies: A Systematic Review and Meta-Analysis
- Food-Related Decision-Making at Home After Recurrent Esophagogastric Variceal Bleeding in Patients with Cirrhosis: A Qualitative Descriptive Study.
- Gastrointestinal complications in patients with aneurysmal subarachnoid hemorrhage: a systematic review with meta-analysis of gastrointestinal bleeding incidence
BibTeX
@article{krommenhoek2026incidence,
title = {{Incidence of Recurrent Major Bleeding and its Impact on Survival in LVAD Patients: A Multistate Analysis}},
author = {Jurjen F. Krommenhoek and Eva Janssen and Paul L. den Exter and Sabine F.B. van der Horst and Saskia L.M.A. Beeres and Jesper Hjortnaes and Meindert Palmen and Frederikus A. Klok and Nienke van Rein and Marta Fiocco and Wouter Jukema and Laurens F. Tops},
journal = {TH Open: Companion Journal to Thrombosis and Haemostasis},
year = {2026},
month = oct,
doi = {10.1055/a-2976-7540},
url = {https://doi.org/10.1055/a-2976-7540},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Incidence of Recurrent Major Bleeding and its Impact on Survival in LVAD Patients: A Multistate Analysis
AU - Jurjen F. Krommenhoek
AU - Eva Janssen
AU - Paul L. den Exter
AU - Sabine F.B. van der Horst
AU - Saskia L.M.A. Beeres
AU - Jesper Hjortnaes
AU - Meindert Palmen
AU - Frederikus A. Klok
AU - Nienke van Rein
AU - Marta Fiocco
AU - Wouter Jukema
AU - Laurens F. Tops
PY - 2026
DA - 2026/10/21
JO - TH Open: Companion Journal to Thrombosis and Haemostasis
DO - 10.1055/a-2976-7540
UR - https://doi.org/10.1055/a-2976-7540
AB - Introduction Major bleeding frequently complicates the clinical course of left ventricular assist device (LVAD) therapy. However, data on recurrent major bleeding in destination therapy (DT) patients, as well as its impact on survival, are limited. Methods Single-center cohort of 122 predominantly DT LVAD between 2010 and 2024. A multistate model was estimated to evaluate first and recurrent major bleeding, and all-cause mortality. Patients who died within 14 days following implantation were excluded from the analysis. Results For the final analysis 116 patients (90 HeartWare HVAD; 26 HeartMate 3) were included; median age at implantation was 64 years (IQR 59–69 years); 80% were male and 56% had ischemic heart failure. During a follow-up period totaling 300 patient-years, 155 major bleeding episodes occurred in 60 patients. Half of the patients who experienced a first major bleeding ( n = 60) went on to develop a subsequent recurrence ( n = 30). Recurrence often occurred within a short interval after the initial major bleeding. Among these recurrences, 43% occurred at the same site as the initial major bleeding. Conclusion Following an initial major bleeding, LVAD patients frequently experienced either recurrent major bleeding or death within a short interval. The overall incidence of (recurrent) major bleeding was high. These findings highlight the burden of recurrent bleeding events and their impact on DT LVAD patients.
SN - 2567-3459
SN - 2512-9465
ER -